Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock

Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock

Background: Early goal-directed therapy (EGDT) is recommended in international guidance for the resuscitation of patients presenting with early septic shock. However, adoption has been limited and uncertainty remains over its clinical effectiveness and cost-effectiveness. Objectives: The primary obj...

Full description

Bibliographic Details
Main Authors: Paul R Mouncey, Tiffany M Osborn, G Sarah Power, David A Harrison, M Zia Sadique, Richard D Grieve, Rahi Jahan, Jermaine CK Tan, Sheila E Harvey, Derek Bell, Julian F Bion, Timothy J Coats, Mervyn Singer, J Duncan Young, Kathryn M Rowan
Format: Article
Language:English
Published: NIHR Journals Library 2015-11-01
Series:Health Technology Assessment
Subjects:
promise
randomised controlled trial
clinical effectiveness
cost-effectiveness
septic shock
early goal-directed therapy
resuscitation
Online Access:https://doi.org/10.3310/hta19970

Internet

https://doi.org/10.3310/hta19970

Similar Items